Tuesday, February 28, 2017 6:19:20 PM
RDAR filed a SEC Form 15
and voluntarily terminated its registration
under Section 12(G) of the securities act of 1934.
As such, RDAR no longer has a requirement to file
annual and quarterly financial reports
directly with the SEC.
However, in order to provide its shareholders
current financial and other information on the company,
the Board plans on filing Annual and Quarterly reports.
"Over and above becoming a SEC fully reporting company,
we understand the desire of our shareholders to uplift
to a higher exchange and the open flow of communication,
so the next logical step is the OTCQB”, says DiMartino.
The company's focus is
to become fully reporting
and qualify for the OTC Pink platform,
which calls for a $0.01 closing price
for 30 consecutive days and audited financial records,
which the company estimates to complete with diligence
by close of the second quarter.
In order to support this objective
the company is working to bring all financials
and filings current.
In addition, the company is taking all required actions
to prepare the other company information
and complete the legal and accounting documentation
necessary to prepare and file the application
and complete all other steps required
to accomplish this objective.
http://ih.advfn.com/p.php?pid=nmona&article=73911030&symbol=RDAR
RDAR - Charts / News / Targets
Targets 0.0018 / 0.004 / $0.01 / $0.02
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126171727
RDAR On FAST-TRACK to OTCQB with 12g-4 Filing
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129063897
RDAR - Jump-starting to OTCQB $0.01
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129062239
_________________________________________________________________
RDAR - Targets 0.0018 / 0.004 / $0.01 / $0.02
RDAR - Targets 0.0018 / 0.004 / $0.01 / $0.02
RDAR - Targets 0.0018 / 0.004 / $0.01 / $0.02
Recent RDAR News
- Form 1-A POS - • Edgar (US Regulatory) • 02/28/2024 06:04:50 PM
- Form 1-A POS - • Edgar (US Regulatory) • 01/12/2024 10:24:12 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2023 09:12:20 PM
- Form 253G1 - • Edgar (US Regulatory) • 10/16/2023 01:28:37 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 10/16/2023 04:15:08 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/03/2023 05:20:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM